MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Aging"

  • 2023 International Congress

    Age-associated changes in the striatal proteins in aging Asian-Indians

    H J. Jyothi, A. Mahadevan, T C. Yasha, P. Alladi (Bengaluru, India)

    Objective: To examine the age-related changes in tyrosine hydroxylase (TH), vesicular monoamine transporter2 (VMAT2), post-synaptic density protein-95 (PSD-95) and dopamine receptors (D1R, D2R) expression in the…
  • 2023 International Congress

    Subjective cognitive decline and Frailty in an Asian cohort of patients with Parkinson’s Disease

    P. Venugopalan Menon, K. Gai Fui, E. Elda Kamaruddin, L. Sun, CH. Tan, P. Chong, S. Kumar Seetharaman (Singapore, Singapore)

    Objective: To assess the prevalence of subjective cognitive decline (SCD) and to look for its association with frailty in an Asian cohort of patients with…
  • 2023 International Congress

    Orthostatic hypotension and frailty

    A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

    Objective: to investigate the relationship between functional class of orthostatic hypotension (FC OH) and frailty index (FI). Background: frailty syndrome (FS) as well as orthostatic…
  • 2023 International Congress

    Subjective cognitive complaints in participants of the Healthy Brain Ageing (HeBA) study

    S. Jónsdóttir, C. Pauly, O. Tsurkalenko, E. Thiry, AM. Hanff, T. Marques, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Heisdorf, Luxembourg)

    Objective: To investigate the prevalence of subjective cognitive complaints (SCC) from Healthy Brain Ageing Study (HeBA) participants in Luxembourg, and explore risk factors prevalence which…
  • 2023 International Congress

    GBA haplotypes and age at onset of Parkinson’s disease in the Asian population

    C. Li, R. Ou, Y. Hou, Q. Wei, L. Zhang, K. Liu, J. Lin, X. Chen, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the involvement of GBA haplotypes in age at onset of Parkinson's disease in the Asian population. Background: GBA is an important risk…
  • 2023 International Congress

    Manifestations of aging and Parkinson’s Disease in low-frequency fluctuations of postural sway velocity

    M. Latka, K. Kozlowska, A. Latka, M. Glaubic-Latka, S. Budrewicz, M. Koszewicz, T. Sebzda, BJ. West (Wroclaw, Poland)

    Objective: To distinguish the effects of aging and Parkinson's disease on balance control. Background: Many balance control measures are derived from spontaneous fluctuations of the center…
  • 2023 International Congress

    Estrogen and progesterone influence membrane functions and glucose transporter expression in synaptosomes of different age groups of naturally menopausal rats

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to determine the effect of 17 β-estradiol (E2) and progesterone (P4) on the activities of Na+ K+ ATPase, monoamine…
  • 2023 International Congress

    Efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old;

    A. Ferreira, M. Rodrigues (Braga, Portugal)

    Objective: To search for any differences between efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old. Background: Safinamide…
  • 2023 International Congress

    The prevalence of Parkinson’s disease in a predominantly rural area of North West England

    R. Varden, R. Walker, A. O'Callaghan (Carlilse, United Kingdom)

    Objective: To calculate the crude and age adjusted prevalence of Parkinson’s disease (PD) in North Cumbria. Background: Prevalence data give insight into disease cause and…
  • 2023 International Congress

    Gemini digital twins identified neuro-common and disease-specific drivers of rate of change in NfL in Huntington’s disease, Parkinson disease and Alzheimer disease

    X. Shen, S. Sathe, L. Sun, P. Ashrap, K. Johnson, S. Sukhram, S. Reddy, S. Shin, J. Latourelle, C. Sampaio (Somerville, USA)

    Objective: Identify common and disease specific molecular drivers of rate of change in Neurofilament light (NfL) in Huntington’s disease (HD), Parkinson disease (PD) and Alzheimer…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 22
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley